Quest Diagnostics teams up with Google Cloud to streamline data and personalize customer experiences using gen AI.

Under the partnership, the Secaucus-based company becomes the first national laboratory to implement these services across a range of areas.

Baird raised the firm’s price target on Quest Diagnostics (DGX) to $191 from $190 and keeps an Outperform rating on the shares. The firm ...

Artificial Intelligence (AI) and Machine Learning (ML) play a pivotal role in precision oncology, analyzing vast datasets, ...

Quest Diagnostics adjusts Q1 revenue & EPS outlook due to weather impact, projects 4-5% CAGR revenue growth beyond 2025. Read ...

In a groundbreaking series of announcements at its GTC conference, NVIDIA on Tuesday unveiled a portfolio of AI-driven ...

Investing.com -- Quest Diagnostics (NYSE: NYSE: DGX ), a prominent player in diagnostic information services, announced today ...

Quest Diagnostics announced it is teaming up with Google Cloud to develop artificial intelligence programs that can ...

Quest said it aims through the collaboration to streamline data management, improve data analytics, and personalize the experiences of its patients.

Quest Diagnostics (DGX) announced a collaboration with Google (GOOG) Cloud to streamline Quest’s data management, improve data analytics, and ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced a collaboration with Google Cloud to streamline Quest's data management, improve data analytics, and ...

Google also said Tuesday that it has been updating a new AI system to help researchers speed up their scientific and ...